TITLE

Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors

AUTHOR(S)
Hill, Sarah; Sarfati, Diana; Blakely, Tony; Robson, Bridget; Purdie, Gordon; Chen, Jarvis; Dennett, Elizabeth; Cormack, Donna; Cunningham, Ruth; Dew, Kevin; McCreanor, Tim; Kawachi, Ichiro
PUB. DATE
February 2010
SOURCE
Journal of Epidemiology & Community Health;Feb2010, Vol. 64 Issue 2, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Ethnic disparities in cancer survival have been documented in many populations and cancer types. The causes of these inequalities are not well understood but may include disease and patient characteristics, treatment differences and health service factors. Survival was compared in a cohort of Maori (Indigenous) and non-Maori New Zealanders with colon cancer, and the contribution of demographics, disease characteristics, patient comorbidity, treatment and healthcare factors to survival disparities was assessed. Methods Maori patients diagnosed as having colon cancer between 1996 and 2003 were identified from the New Zealand Cancer Registry and compared with a randomly selected sample of non-Maori patients. Clinical and outcome data were obtained from medical records, pathology reports and the national mortality database. Cancer-specific survival was examined using Kaplan—Meier survival curves and Cox hazards modelling with multivariable adjustment. Results 301 Maori and 328 non-Maori patients with colon cancer were compared. Maori had a significantly poorer cancer survival than non-Maori (hazard ratio (HR)=1.33, 95% CI 1.03 to 1.71) that was not explained by demographic or disease characteristics. The most important factors contributing to poorer survival in Maori were patient comorbidity and markers of healthcare access, each of which accounted for around a third of the survival disparity. The final model accounted for almost all the survival disparity between Maori and non-Maori patients (HR=1.07, 95% CI 0.77 to 1.47). Conclusion Higher patient comorbidity and poorer access and quality of cancer care are both important explanations for worse survival in Maori compared with non-Maori New Zealanders with colon cancer.
ACCESSION #
49312011

 

Related Articles

  • Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries. Zhehui Luo; Bradley, Cathy J.; Dahman, Bassam A.; Gardiner, Joseph C. // Health Care Financing Review;Fall2009, Vol. 31 Issue 1, p35 

    To estimate the cost attributable to colon cancer treatment 1 year after diagnosis by cancer stage, comorbidity, treatment regimen, and Medicaid eligibility, we extracted an inception cohort of colon cancer patients aged 66 and older diagnosed between 1997 and 2000 from the Michigan Tumor...

  • Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care. Asmis, T. R.; Powell, E.; Karapetis, C. S.; Jonker, D. J.; Tu, D.; Jeffery, M.; Pavlakis, N.; Gibbs, P.; Zhu, L.; Dueck, D.-A.; Whittom, R.; Langer, C.; O'Callaghan, C. J. // Annals of Oncology;Jan2011, Vol. 22 Issue 1, p118 

    Background: The interplay between comorbidity, age and performance status (PS) as predictors of outcome in advanced colorectal cancer (ACRC) is poorly understood. We examined these factors as predictors of treatment toxicity and outcome in cetuximab-treated patients with ACRC.Patients and...

  • EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review. Quirke, P.; West, N.; Nagtegaal, I. // Virchows Archiv;Feb2014, Vol. 464 Issue 2, p129 

    Care for patients with colon and rectal cancer has improved in the last 20 years; however, a considerable variation still exists in cancer management and outcome between European countries. Large variation is also apparent between national guidelines and patterns of cancer care in Europe....

  • Does young age influence the prognosis of colorectal cancer: a population-based analysis. McKay, Andrew; Donaleshen, Jeniva; Helewa, Ramzi M.; Park, Jason; Wirtzfeld, Debrah; Hochman, David; Singh, Harminder; Turner, Donna // World Journal of Surgical Oncology;2014, Vol. 12 Issue 1, p1 

    Background Controversy exists whether young patients diagnosed with colorectal cancer have a poorer prognosis. Although younger patients are more likely to have certain poor prognostic factors, prior studies have shown mixed results in terms of overall prognosis, which may be due to lack of...

  • Outcomes of Simultaneous Laparoscopic Colorectal and Hepatic Resection for Patients with Colorectal Cancers: A Comparative Study. Jung, Kyung Uk; Kim, Hee Cheol; Cho, Yong Beom; Kwon, Choon Hyuck David; Yun, Seong Hyeon; Heo, Jin Seok; Lee, Woo Yong; Chun, Ho-Kyung // Journal of Laparoendoscopic & Advanced Surgical Techniques;Apr2014, Vol. 24 Issue 4, p229 

    Background: Although laparoscopic colorectal resection and laparoscopic liver resection have been accepted as effective alternatives to conventional open procedures, there are only a few reports on the clinical availability of simultaneous performance of these two procedures. We report our...

  • Clinicopathological characteristics and long-term outcomes of colorectal cancer in elderly Chinese patients undergoing potentially curative surgery. Yang, Zuli; Chen, Hao; Liao, Yi; Xiang, Jun; Kang, Liang; Wang, Lei; Cui, Ji; Cai, Guanfu; Peng, Junsheng; Lan, Ping; Wang, Jianping // Surgery Today;Jan2014, Vol. 44 Issue 1, p115 

    Purpose: The aim of this study was to determine the clinicopathological characteristics and outcomes of Chinese colorectal cancer (CRC) patients aged 75 years and older undergoing potentially curative surgery. Methods: A total of 2,482 CRC patients at TNM stage I-III undergoing surgical...

  • Characterisation of E12/E47 expression in colorectal cancer. Chugha, A. S.; Flanagan, L.; Bane, F.; Young, L.; D'Orsi, B.; Prehn, J. H. M. // BMC Proceedings;1/14/2015, p1 

    The article discusses a conference paper about the characterization of E2A transcriptional regulator proteins E12/E47 expression in colorectal cancer (CC) that was presented at the International Conference for Healthcare & Medical Students held in Dublin, Ireland from October 11-12, 2013. It...

  • Social and geographic disparities in access to reference care site for patients with colorectal cancer in France. Dejardin, O.; Bouvier, A.-M.; Herbert, C.; Velten, M.; Buemi, A.; Delafosse, P.; Maarouf, N.; Boutreux, S.; Launoy, G. // British Journal of Cancer;5/23/2005, Vol. 92 Issue 10, p1842 

    The aim of this study was to investigate the relationship between social and geographic characteristics and the type of care centre for initial colorectal surgery in France. Patients living far from a reference cancer site were less frequently treated in a reference cancer site than those who...

  • Results of Cancer Care Quality Study Lead to Cautious Optimism, Caveats. Christensen, Damaris // JNCI: Journal of the National Cancer Institute;8/4/2004, Vol. 96 Issue 15, p1124 

    Reports on the findings of a study about the quality of care received by cancer patients in the United States. Medical treatment of people with breast or colorectal cancer; Gaps in the quality of cancer care; Surgical care.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics